These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38689449)

  • 1. Bilateral Adrenal Metastasis of Prostatic Adenocarcinoma on 68 Ga-PSMA PET/CT Imaging.
    Beyhan E; Turan Bektaş C; Baloğlu MC; Tosunoğlu Z; Çermik TF
    Clin Nucl Med; 2024 Jul; 49(7):e324-e326. PubMed ID: 38689449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous, Subcutaneous, and Bilateral Adrenal Gland Metastases in Progressive Prostate Carcinoma: Theranostic Potential of 68 Ga-PSMA-11 PET/CT Imaging and 177 Lu-PSMA-617 Therapy.
    Parghane RV; Basu S
    Clin Nucl Med; 2024 Jun; 49(6):587-588. PubMed ID: 38557426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-Body
    Pomykala KL; Czernin J; Grogan TR; Armstrong WR; Williams J; Calais J
    J Nucl Med; 2020 Mar; 61(3):405-411. PubMed ID: 31541035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Metastatic Prostate Cancer Presenting With Atypical Lower-Limb Skeletal Metastases Detected on 68 Ga-PSMA PET/CT.
    Yip A; Yap J
    Clin Nucl Med; 2024 Jul; 49(7):e346-e350. PubMed ID: 38687004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma.
    Zhao Q; Yang B; Dong A; Zuo C
    Clin Nucl Med; 2022 Jan; 47(1):e101-e102. PubMed ID: 34115707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental Finding of Spindle Cell Sarcoma on 68 Ga-PSMA-11 PET/CT.
    Anigati EM; Nguyen NC
    Clin Nucl Med; 2024 Aug; 49(8):e423-e424. PubMed ID: 38620001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the performance of [
    Abufaraj M; Grubmüller B; Zeitlinger M; Kramer G; Seitz C; Haitel A; Baltzer P; Hacker M; Wadsak W; Pfaff S; Wiatr T; Mitterhauser M; Shariat SF; Hartenbach M
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2169-2177. PubMed ID: 31254037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Mainta IC; Neroladaki A; Wolf NB; Benamran D; Boudabbous S; Zilli T; Garibotto V
    J Nucl Med; 2024 Sep; 65(9):1376-1382. PubMed ID: 39117453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent prostate cancer: combined role for MRI and PSMA-PET in
    Jannusch K; Bruckmann NM; Morawitz J; Boschheidgen M; Quick HH; Herrmann K; Fendler WP; Umutlu L; Stuschke M; Hadaschik B; Antoch G; Schimmöller L; Kirchner J
    Eur Radiol; 2024 Jul; 34(7):4789-4800. PubMed ID: 38038758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Gallium-68 prostate-specific membrane antigen, positron emission tomography/computed tomography (GA-68 PSMA PET/CT) in recurrent prostate cancer: a retrospective review of initial clinical experience at Tygerberg Hospital.
    Sangiwa BA; Burger C; Ellmann A
    Pan Afr Med J; 2024; 48():30. PubMed ID: 39220559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between whole body volumetric parameters of
    Yildirim ÖA; Gündoğan C; Can C; Poyraz K; Erdur E; Kömek H
    Ann Nucl Med; 2021 May; 35(5):540-548. PubMed ID: 33586097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense 68 Ga-PSMA Uptake in Neurofibroma Mimicking Cutaneous Metastases in a Patient With Prostate Cancer.
    Erol Fenercioğlu Ö; Beyhan E; Leblebici C; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Oct; 47(10):e637-e639. PubMed ID: 35452001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of
    Topuz ÖV; Aksu A; Erinç SR; Tamam MÖ
    Hell J Nucl Med; 2021; 24(1):60-65. PubMed ID: 33866340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Bock F; Frerker B; Schubert L; Rennau H; Kurth J; Krause BJ; Hildebrandt G; Schwarzenböck SM
    Nuklearmedizin; 2024 Jun; 63(3):199-206. PubMed ID: 38580313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Simsek DH; Sanli Y; Civan C; Engin MN; Isik EG; Ozkan ZG; Kuyumcu S
    Ann Nucl Med; 2020 Jul; 34(7):476-485. PubMed ID: 32394269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of
    Li S; Nguyen A; Counter W; John NC; De Leon J; Hruby G; Joshua AM; Stricker P; Crumbaker M; Ayati N; Chan L; Sabahi Z; Swiha M; Kneebone A; Wong K; Liu V; Sharma S; Agrawal S; Emmett LM
    J Nucl Med; 2024 Sep; 65(9):1371-1375. PubMed ID: 39089814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of
    Afaq A; Alahmed S; Chen SH; Lengana T; Haroon A; Payne H; Ahmed H; Punwani S; Sathekge M; Bomanji J
    J Nucl Med; 2018 Jan; 59(1):89-92. PubMed ID: 28747520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.